B7-33
cardiovascular pulmonary healthhealing tissue repair
Dosing Schedule (Subcutaneous)
| Phase | Daily Dose (mcg) |
|---|---|
| Introductory | 150 mcg (0.15 mg) |
| Standard Research | 300 mcg (0.3 mg) |
| Intensive | 500 mcg (0.5 mg) |
Frequency: Once per day (subcutaneous).
Timing: Evening administration to mirror natural relaxin surges.
Cycle Length: 4–8 weeks for acute fibrosis studies.
Need B7-33?
Lab-tested research peptides from N1 Aminos